Diagnostic Testing & Technology Report

One-third of men in the United States over 75 are receiving prostate-specific antigen (PSA) testing, but the U.S. Preventive Services Task Force warns that such testing could do more harm than good. According to a recommendation and analysis published in the August 5 issue of the Annals of Internal Medicine, men age 75 and older should not be screened for prostate cancer, and younger men should discuss the benefits and harms of the PSA test with their clinicians before being tested.